No black box warning on record for Valrubicin Intravesical Solution

As of the latest FDA labeling reviewed, Valrubicin Intravesical Solution (VALRUBICIN INTRAVESICAL SOLUTION) does not carry a black box warning. Standard warnings and precautions still apply — see the full Valrubicin Intravesical Solution medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Delaying cystectomy can lead to development of metastatic bladder cancer, which is lethal. ( 5.1 ) • Do not administer valrubicin intravesical solution to patients with a perforated bladder or to those in whom the integrity of the bladder mucosa has been compromised. ( 5.2 , 12.3 ) • Evaluate the status of the bladder before the intravesical instillation of valrubicin

No black box warning on record for Valrubicin Intravesical Solution

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Delaying cystectomy can lead to development of metastatic bladder cancer, which is lethal. ( 5.1 ) • Do not administer valrubicin intravesical solution to patients with a perforated bladder or to those in whom the integrity of the bladder mucosa has been compromised. ( 5.2 , 12.3 ) • Evaluate the status of the bladder before the intravesical instillation of valrubicin

Valrubicin Intravesical Solution Black Box Warning

No black box warning on record for Valrubicin Intravesical Solution

Other warnings & precautions

Valrubicin Intravesical Solution Black Box Warning

No black box warning on record for Valrubicin Intravesical Solution

Other warnings & precautions